MedTrace Logo

Prevalence and Prognostic Relevance of Tricuspid Regurgitation in Different Heart Failure Entities

NCT04570098 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1016

Last updated 2025-02-12

No results posted yet for this study

Summary

The present study includes patients with tricuspid regurgitation and heart failure diagnosed with echocardiography. The aim is to evaluate the physical performance of patients with tricuspid regurgitation and heart failure, to observe the course of the diseases and to allow a better understanding of new therapy options.

Conditions

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-26
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04570098 on ClinicalTrials.gov